Saccharide Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Saccharide Therapeutics General Information
Description
Developer of synthetic glycoconjugate vaccines intended to protect against deadly infectious diseases. The company is advancing a pipeline of synthetic glycoconjugate vaccines that target highly conserved elements across multiple pathogens, including malaria, tuberculosis, and invasive fungal infections, enabling global health organizations to access novel synthetic vaccines designed to provide high levels of protection against major global pathogens.
Contact Information
Website
www.saccharidetx.comCorporate Office
- Southbank, Victoria
- Australia
Corporate Office
- Southbank, Victoria
- Australia
Saccharide Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 01-Sep-2026 | Completed | Clinical Trials - Phase 1 | |||
| 1. Early Stage VC | Completed | Clinical Trials - Phase 1 |
Saccharide Therapeutics Signals
Saccharide Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biointelect | Accelerator/Incubator | |||
| La Ferla Ventures | Venture Capital | Minority |
Saccharide Therapeutics FAQs
-
When was Saccharide Therapeutics founded?
Saccharide Therapeutics was founded in 2024.
-
Where is Saccharide Therapeutics headquartered?
Saccharide Therapeutics is headquartered in Southbank, Australia.
-
What is the size of Saccharide Therapeutics?
Saccharide Therapeutics has 2 total employees.
-
What industry is Saccharide Therapeutics in?
Saccharide Therapeutics’s primary industry is Biotechnology.
-
Is Saccharide Therapeutics a private or public company?
Saccharide Therapeutics is a Private company.
-
What is Saccharide Therapeutics’s current revenue?
The current revenue for Saccharide Therapeutics is .
-
Who are Saccharide Therapeutics’s investors?
Biointelect and La Ferla Ventures have invested in Saccharide Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process